Clinical trial

Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With Breast Cancer Treated With Trastuzumab Deruxtecan

NCT07828054

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-12-20

PhasePHASE3

Study timeline

Study start (estimated)2026-12-20Date precision: day

Registry last updated2026-09-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interstitial Lung Disease (ILD)unresolved

Interventions

DexamethasoneDRUG · verified · RxNorm: dexamethasone

antiemetic premedicationDRUG

T-DXdDRUG

Sponsors & collaborators

Mario Negri Institute for Pharmacological Researchlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07828054 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.